THE PRESENT STUDY WAS CONDUCTED to determine the clinical effects of n
ifedipine on the gingiva of 97 patients. Patients were examined for ch
anges in periodontal status and divided into subgroups, based on their
age, gender, duration of drug intake, presence/absence of plaque and
gingival inflammation, and according to the presence and severity of g
ingival overgrowth. Gingival overgrowth was noticed in 29% of the pati
ents. Among the recorded parameters, duration of drug intake, presence
/severity of gingival inflammation, and gender seemed to have the grea
test effect on the development of gingival overgrowth. Patients with h
igher gingival inflammation scores, those on nifedipine medication for
more than 4 years, and males were likely to have an increased tendenc
y for higher incidence and severity of gingival overgrowth. The findin
gs of the present study suggest that nifedipine medication induces gin
gival overgrowth and that certain local factors are involved in the pa
thogenesis of drug-induced gingival overgrowth. However, individual ab
ility and sensitivity to metabolize the drug and its metabolites also
seem to be important etiological factors.